Pegcetacoplan
APL2-DGF-318
Phase 3 small_molecule active
Quick answer
Pegcetacoplan for Delayed Graft Function is a Phase 3 program (small_molecule) at Apellis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Apellis Pharmaceuticals
- Indication
- Delayed Graft Function
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active